Sensitive LC-MS/MS approach for the quantification of proteolysis targeting chimeras in a biological matrix

PROTACs are protein degraders that harness the cell’s disposal machinery to remove specific targets. Now advancing into clinical trials, they show high potency at nanomolar levels. To support safe and effective drug development, sensitive and selective assays are essential for reliable detection and quantification.